Company Filing History:
Years Active: 2016-2017
Title: Innovations by Krystin A Bedard in Atypical Hemolytic Uremic Syndrome
Introduction
Krystin A Bedard is an accomplished inventor based in Auburn Hills, MI (US). She has made significant contributions to the field of medical research, particularly in the area of atypical hemolytic uremic syndrome (aHUS). With a total of 2 patents, her work focuses on developing biomarker proteins that can aid in the diagnosis and treatment of this serious condition.
Latest Patents
Krystin's latest patents revolve around biomarker proteins associated with atypical hemolytic uremic syndrome (aHUS). These patents disclose biomarker proteins whose concentration or activity levels are linked to aHUS. The inventions provide compositions and methods for assessing these biomarker proteins in biological fluids. This innovation is crucial for evaluating the risk of developing aHUS, diagnosing the condition, and monitoring treatment responses.
Career Highlights
Krystin A Bedard is currently employed at Alexion Pharmaceuticals, Inc., where she continues to advance her research in aHUS. Her work is instrumental in developing effective treatments and diagnostic tools for this condition.
Collaborations
Some of her notable coworkers include Susan Faas Mcknight and Roxanne Cofiell, who contribute to the collaborative efforts in their research endeavors.
Conclusion
Krystin A Bedard's innovative work in the field of atypical hemolytic uremic syndrome exemplifies the impact of research on medical advancements. Her contributions are paving the way for better diagnostic and treatment options for patients suffering from this condition.